Australian Clinical Labs Ltd (ACL) — Cash Flow Quality Index
Australian Clinical Labs Ltd (ACL) has a Cash Flow Quality Index of 11.29x as of December 2025. Operating cash flow of AU$62.87 Million exceeds net income of AU$5.57 Million, indicating high earnings quality where cash backs reported profits. Explore ACL long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Australian Clinical Labs Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Australian Clinical Labs Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Australian Clinical Labs Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Australian Clinical Labs Ltd (2019–2025)
Year-by-year earnings quality comparison for Australian Clinical Labs Ltd. For live market cap and the full company financial profile, see how much is Australian Clinical Labs Ltd worth.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.64x | AU$182.80 Million | AU$32.43 Million | ▲ +0.0% |
| 2024 | 5.64x | AU$182.80 Million | AU$32.43 Million | ▼ -15.5% |
| 2024 | 6.67x | AU$159.59 Million | AU$23.93 Million | ▲ +0.0% |
| 2023 | 6.67x | AU$159.59 Million | AU$23.93 Million | ▲ +66.6% |
| 2023 | 4.00x | AU$143.68 Million | AU$35.90 Million | ▲ +0.0% |
| 2022 | 4.00x | AU$143.68 Million | AU$35.90 Million | ▲ +151.1% |
| 2022 | 1.59x | AU$284.09 Million | AU$178.24 Million | ▲ +0.0% |
| 2021 | 1.59x | AU$284.09 Million | AU$178.24 Million | ▼ -37.5% |
| 2021 | 2.55x | AU$153.86 Million | AU$60.37 Million | ▲ +0.0% |
| 2020 | 2.55x | AU$153.86 Million | AU$60.37 Million | ▲ +3.3% |
| 2020 | 2.47x | AU$101.74 Million | AU$41.26 Million | ▲ +0.0% |
| 2019 | 2.47x | AU$101.74 Million | AU$41.26 Million | — |